COMPANY PROFILE
FullHope Biomedical Co., Ltd. (FHB) was founded by professional immunologists and managers in 2012, and aimed to establish immune cell-based immunotherapy to cancer and autoimmune disorders via innovative cell technology and clinical trail proving.
FHB headquarter is located at Thomas Scientific Park, New Taipei city. Within the headquarter, FHB constructed a professional researching and manufacturing facility composing three functional laboratories; (1) Good Tissue Practice (GTP) laboratory for immune cell product generation, (2) preclinical laboratory for innovative immune cell characterization, and (3) Taiwan Accreditation Foundation (TAF) certificated ISO/IEC 17025 testing laboratory for quality insurance of immune cell products. Furthermore, FHB cooperates with national research institute and medical center hospitals to consolidate FHB-owned cell technologies in future clinical trials and treatments.
Currently, FHB filed more than fifteen patents regarding cell technologies, and six of them were approved by TIPO and USIPO respectively. FHB has also been awarded by receiving grants of Small Business Innovation Research (SBIR) Taiwan. To strength innovative research and clinical trials conducted in medical center or institute, FHB has finished three rounds of fund raising to reach the capital by 146 million NTD until November 2015. All together, FHB has constructed advanced researching and manufacturing facility to continue IND Phase trials of innovative cell products with medical center and research institute, and also seek for cooperation with global partners to extend our international marketing development.